Teva- Pharmaceutical Industries Ltd ADR (TEVA): Next-Year EPS Estimate 37.49%
As of 2026-06-04, Teva- Pharmaceutical Industries Ltd ADR (TEVA) has a next-year EPS growth estimate of 37.49%.
On 2026-05-27, analyst consensus for TEVA's next-year EPS growth shifted from 37.45% to 37.49% — a positive change of 0.04 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at -23.03%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 37.49%
- EPS growth this year
- -23.03%
- EPS next quarter (est)
- $0.60
- Last price
- $34.43
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 37.49% | -23.03% | $0.60 | $34.43 |
| 2026-06-03 | 37.49% | -23.03% | $0.60 | $32.83 |
| 2026-06-02 | 37.49% | -23.03% | $0.60 | $33.08 |
| 2026-06-01 | 37.49% | -23.03% | $0.60 | $34.64 |
| 2026-05-31 | 37.49% | -23.03% | $0.60 | $35.32 |
| 2026-05-28 | 37.49% | -23.03% | $0.60 | $34.52 |
| 2026-05-27 | 37.49% | -23.03% | $0.60 | $34.56 |
| 2026-05-26 | 37.45% | -23.02% | $0.60 | $34.61 |
| 2026-05-25 | 37.45% | -23.02% | $0.60 | $34.07 |
| 2026-05-24 | 37.45% | -23.02% | $0.60 | $34.07 |
| 2026-05-21 | 37.45% | -23.02% | $0.60 | $34.16 |
| 2026-05-20 | 37.45% | -23.02% | $0.60 | $34.32 |
| 2026-05-19 | 37.45% | -23.02% | $0.60 | $34.07 |
| 2026-05-18 | 37.45% | -23.02% | $0.60 | $34.03 |
| 2026-05-17 | 37.45% | -23.02% | $0.60 | $34.29 |
| 2026-05-14 | 37.45% | -23.02% | $0.60 | $35.31 |
| 2026-05-13 | 37.45% | -23.02% | $0.60 | $36.13 |
| 2026-05-12 | 37.45% | -23.02% | $0.60 | $35.81 |
| 2026-05-11 | 37.45% | -23.02% | $0.60 | $35.84 |
| 2026-05-10 | 34.50% | -21.33% | $0.60 | $35.73 |
| 2026-05-07 | 34.50% | -21.33% | $0.60 | $36.01 |
| 2026-05-06 | 34.50% | -21.33% | $0.60 | $36.34 |
| 2026-05-05 | 34.50% | -21.33% | $0.60 | $35.86 |
| 2026-05-04 | 30.70% | -19.08% | $0.60 | $35.35 |
| 2026-05-03 | 30.70% | -19.08% | $0.60 | $34.95 |
| 2026-04-30 | 27.99% | -17.31% | $0.60 | $35.07 |
Recent News
- Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond TargetsGlobeNewswire
- Teva signs off $900m Emalex buyout amid strategic pipeline boosting ployPharmaceutical Technology
- Teva Pharmaceutical Industries Ltd (TEVA) Q1 2026 Earnings Call Highlights: Strong Innovative ...GuruFocus.com
- Teva Surges As Its New Growth Strategy Hits A Key Inflection PointInvestor's Business Daily
- Teva nabs experimental Tourette drug in $700M Emalex buyoutBioPharma Dive
- Medincell - UZEDY: Q1 2026 Net Sales Reached $63M, Up 62% Year-on-YearBusiness Wire
- Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined ExecutionGlobeNewswire
- Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva's Pivot to Growth StrategyGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Teva- Pharmaceutical Industries Ltd ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Teva- Pharmaceutical Industries Ltd ADR (TEVA) has a next-year EPS growth estimate of 37.49%, based on analyst consensus.
When was the latest EPS estimate revision for TEVA?▾
The most recent revision occurred on 2026-05-27, when analysts adjusted the next-year EPS growth estimate from 37.45% to 37.49%.
What sector and industry does Teva- Pharmaceutical Industries Ltd ADR belong to?▾
Teva- Pharmaceutical Industries Ltd ADR operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TEVA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Teva- Pharmaceutical Industries Ltd ADR (TEVA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports